Chord Therapeutics is a series a startup. 1 investor tracked. Status: possibledead.
Chord Therapeutics is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Chord Therapeutics is a biotechnology company focused on developing and commercializing treatments for rare and severe autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.